American Hospital Association, 340B Health, America’s Essential Hospitals, Association of American Medical Colleges, National Association of Children’s Hospitals d/b/a Children’s Hospital Association, and American Society of Health-System Pharmacists, by and through their undersigned attorneys, hereby file this amicus brief in support of Defendants’ opposition to the motion for summary judgment filed by AstraZeneca Pharmaceuticals LP (AstraZeneca).
340B Drug Pricing Program Legal Resources
Latest
Motion and Memorandum in Support of Motion to Intervene NOVO NORDISK v Cochran (March 2, 2021)
IN THE UNITED STATES DISTRICT COURT
FOR THE DISTRICT OF NEW JERSEY
Government’s Opposition to Motion to Intervene - AstraZeneca v. Cochran (March 12, 2021)
AstraZeneca’s Opposition to Motion to Intervene (March 12, 2021) Insert
Associations’ Reply in Support of Motion to Intervene - AstraZeneca v. Cochran (March 19, 2021)
American Hospital Association, 340B Health, America’s Essential Hospitals, Association of American Medical Colleges, National Association of Children’s Hospitals d/b/a Children’s Hospital Association, and American Society of HealthSystem Pharmacists (collectively the “Proposed Intervenors”) move this Court, pursuant to Federal Rule of Civil Procedure 24(a) or in the alternative pursuant to Federal Rule of Civil Procedure 24(b), for an Order granting their Motion to Intervene in this lawsuit regarding the 340B Drug Discount Program.
Response to Motion to Intervene - SANOFI-AVENTIS vs HHS (March 22, 2021)
UNITED STATES DISTRICT COURT
FOR THE SOUTHERN DISTRICT OF INDIANA
INDIANAPOLIS DIVISION
IN THE UNITED STATES DISTRICT COURT
FOR THE SOUTHERN DISTRICT OF INDIANA
INDIANAPOLIS DIVISION
Amicus Brief–Hospital Systems - 340B Payment Reductions March 12 2021
UNITED STATES DISTRICT COURT
FOR THE DISTRICT OF DELAWARE
ASTRAZENECA PHARMACEUTICALS LP
Amicus Brief-State and Regional Hosp Associations 340B Case
Memorandum in Support of Motion to Intervene regarding 340B Contract Pharmacy
Order granting motion to dismiss regarding 340B Contract Pharmacy.
QUESTION PRESENTED: The question presented is whether Chevron deference permits HHS to set reimbursement rates based on acquisition cost and vary such rates by hospital group if it has not collected adequate hospital acquisition cost survey data.
Plaintiffs' Response to Order to Show Cause Opposition to Defendants' Motion to Dismiss and Reply in Support of Plaintiffs' Motion for a Preliminary Injunction Re: 340B Contract Pharmacy
Order to show Cause RE: Dismissal for Lack of Subject-Matter Jurisdiction